Handelin

CAS No. 62687-22-3

Handelin ( —— )

Catalog No. M24627 CAS No. 62687-22-3

Handelin has anti-inflammatory activity by inhibiting NF-κB activation and pro-inflammatory cytokine productions.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 160 In Stock
10MG 267 In Stock
25MG 443 In Stock
50MG 646 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Handelin
  • Note
    Research use only, not for human use.
  • Brief Description
    Handelin has anti-inflammatory activity by inhibiting NF-κB activation and pro-inflammatory cytokine productions.
  • Description
    Handelin has anti-inflammatory activity by inhibiting NF-κB activation and pro-inflammatory cytokine productions.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    inflammation;NF-κB
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    62687-22-3
  • Formula Weight
    552.7
  • Molecular Formula
    C32H40O8
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C[C@]([C@]([C@@](OC1=O)([H])[C@@](C1=C)([H])CC[C@]2(O)C)([H])[C@@]32C4)(C=C3)[C@]54[C@@]([C@H]6OC(C)=O)([H])[C@]([C@](C(C)=CC7)([H])[C@]7([H])[C@](C)(O)C6)([H])OC5=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Request full-text Anti-inflammatory activity of handelin through the modulation of NF-κB signaling and pro-inflammatory cytokine productionsPlanta Med 2012; 78 - PD86.
molnova catalog
related products
  • (R)-Reticuline

    (R)-Reticuline is the biosynthetic precursor of the morphinan alkaloids.

  • 2-Iodobenzoic acid

    2-Iodobenzoic acid is the impact-sensitive intermediate in the synthesis of the Dess-Martin periodinane.

  • Stiripentol

    Stiripentol (STP) is an anticonvulsant agent, which can inhibit N-demethylation of CLB to NCLB mediated by CYP3A4 (noncompetitively) and CYP2C19 (competitively) with Ki of 1.59/0.516 μM and IC50 of 1.58/3.29 μM, respectively.